product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-BAP1 (Ser592) Antibody
catalog :
9373
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human
application :
western blot, immunoprecipitation
citations: 1
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; loading ...; fig 5m
Jung Y, Cackowski F, Yumoto K, Decker A, Wang J, Kim J, et al. CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes. Cancer Res. 2018;78:2026-2039 pubmed publisher
product information
SKU :
9373S
Product-Name :
Phospho-BAP1 (Ser592) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H
Applications :
Immunoprecipitation
Product-Category :
Ubiquitin and Ubiquitin-like proteins
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
95
Host :
Rabbit
Target :
BAP1 (Ser592) phosphate
Primary-Protein :
BAP1
Alt-Names :
BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),BRCA1-associated protein 1,Cerebral protein 6,DKFZp686N04275,FLJ35406,FLJ37180,HUCEP-13,KIAA0272,UCHL2,Ubiquitin carboxyl-terminal hydrolase BAP1,cerebral protein-13,cerebral protein-6,hucep-6,ubiquitin carboxy-terminal hydrolase
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.